Hydroxychloroquine (HCQS) is recommended for virtually all lupus patients by ACR guidelines — not just for symptom control but to reduce flares, organ damage, and mortality over the long term. This complete guide covers the mechanism, the critical weight-based 5mg/kg/day dosing rule, the 3 to 6 month benefit timeline, mandatory retinal monitoring protocol, and a full DMARD comparison table showing how HCQS fits within the broader lupus and RA treatment landscape.

Rheumatoid arthritis affects 1.5 million Americans — and unlike osteoarthritis, it is an autoimmune disease that attacks the joints and can be stopped with the right treatment. This complete guide covers early warning signs, how RA is diagnosed, and all treatment options from Hydroxychloroquine DMARDs to biologics and JAK inhibitors.